News & Analysis on Clinical Trial Services & Contract Research And Development
Velos has released a new clinical research analytics platform in which the source information is reorganized and reclassified to make it “considerably more useful for clinical research,” says CEO.
Alpha Genesis is investing more than $2m in its European operations to help meet a demand for Zika, Ebola, and flu vaccine development.
Synteract has acquired the dermatology CRO Cu-Tech, opening a fifth center of development as part of its strategy to develop “highly-expert therapeutic areas of focus,” says CCO.
Alvogen has won a court order preventing the Nevada Department of Corrections from using its sedative drug product, midazolam, in an execution.
Pfizer has announced a major shakeup of its business by splitting into three units: Innovative Medicines, Established Medicines and Consumer Healthcare.
Sanofi has suspended production at a French manufacturing facility it says released solvents into the atmosphere.
An EMA survey has found that 42% of businesses, with an important step in their regulatory processes occurring in the UK, are not adequately prepared to retain marketing authorisation post-Brexit.